Health Canada approves first functional cure for some chronic hepatitis B patients
Reported byCBC Health ↗·Sourced by Goodlede
In early November 2026, Health Canada approved a breakthrough drug offering the first functional cure for a portion of chronic hepatitis B patients. Drugmaker GSK expects to roll out the treatment in early 2027. An estimated 260,000 Canadians are living with hepatitis B.
The drug is effective in only a relatively small proportion of hepatitis B patients, and questions remain about cost, access, and how long its effects last.
Goodlede runs a two-pass source check on every story: one pass finds it, a second skeptical pass re-verifies the claim and writes what it doesn’t prove. This is a source check, not an independent fact-check — confirm anything important at the link above.
Read the full story at CBC Health
Read original story ↗More good news, verified daily.
Goodlede covers positive developments across science, nature, rights, and human achievement — verified before they appear. No hype, no roundups, no PR wires.
© 2026 Wag Media, LLC
More from Goodlede
Animals
Belize secures final link in critical wildlife corridor connecting Mesoamerica's largest forest block
Re:wild · Verified
Animals
Grad student finds New Mexico's first Canada lynx in 25 years
Popular Science · Verified
Health
South-East Asia's diabetes and heart disease prevention program reaches 1.75 billion people
Health Policy Watch · Verified